REFRACTORY RENAL CELL CARCINOMA
Clinical trials for REFRACTORY RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for REFRACTORY RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail for advanced kidney cancer shows early promise, but trial halted
Disease control TerminatedThis study tested a new drug (NKT2152) combined with two other medicines (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had worsened after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was …
Matched conditions: REFRACTORY RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New pill shows promise in battling advanced kidney cancer
Disease control TerminatedThis trial tested an oral drug called NKT2152 in 120 people with advanced clear cell kidney cancer that had worsened after other treatments. The goal was to find the safest dose and see if it could shrink tumors. The study was stopped early, but results may help guide future trea…
Matched conditions: REFRACTORY RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC